Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMTX
#6995
Immatics N.V. Ordinary Shares
10.340
0
+4.23%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+4.23%
Aylık değişim
+3.19%
6 aylık değişim
-0.10%
Yıllık değişim
-0.10%
Önceki kapanış
9.920
0
Open
10.340
0
Bid
Ask
Low
10.340
0
High
10.340
0
Hacim
18
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
IMTX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
121.55 M
345.81 M
Valuation ratios
Enterprise value
864.22 M
3.27 B
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Haberler
Immatics Stock: PRAME Leader’s Transition To Commercial Reality (NASDAQ:IMTX)
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Salesforce and Micron Tech among market cap stock movers on Friday
Micron, Salesforce among market cap stock movers on Friday
Leerink Partners eleva el precio objetivo de Immatics a 17 dólares desde 16 dólares
Leerink Partners eleva precio objetivo de Immatics a $17 desde $16
Immatics stock price target raised to $17 from $16 at Leerink Partners
Iovance Biotherapeutics: Several Positives, But Competition Still Threatens (NASDAQ:IOVA)
Company News for Nov 18, 2025
Guggenheim eleva el precio objetivo de Immatics a 19 dólares tras datos positivos del pipeline TCR
Guggenheim raises Immatics stock price target to $19 on positive TCR pipeline data
Immatics NV se quedan por debajo de 0.04€ las previsiones de BPA en el tercer trimestre del año